Nervous system
Memantine (NMDA receptor antagonist)
An NMDA receptor antagonist that damps excessive glutamate stimulation, which may contribute to neuronal injury; used in moderate to severe Alzheimer disease, alone or with a cholinesterase inhibitor.
آلية العمل
- In Alzheimer disease, chronic low-level glutamate overstimulation of NMDA receptors lets in too much calcium (excitotoxicity).
- Memantine blocks the open NMDA channel with low affinity and fast kinetics.
- Pathological, tonic activation is reduced while the brief, strong activation needed for learning is spared.
الأهداف الجزيئية
- NMDA glutamate receptor channel: Uncompetitive (open-channel) blocker
أدوية Memantine (NMDA receptor antagonist)
- Memantine (By mouth; cleared by the kidney.)
الاستخدامات العلاجية
- Moderate to severe Alzheimer disease, alone or added to donepezil
الأمراض التي يعالجها
الآثار الجانبية
- Dizziness and headache
- Confusion and agitation
- Constipation
موانع الاستعمال حسب الحالة
- Kidney impairment (بحذر): It is excreted by the kidney and accumulates.
- Epilepsy (بحذر): It may lower the seizure threshold.
موضوعات مرتبطة
مكتوب من
- Lippincott Illustrated Reviews: Pharmacology, 7th ed., Ch. 8, Drugs for Neurodegenerative Diseases, NMDA receptor antagonist
- Basic & Clinical Pharmacology (Katzung), 14th ed., Ch. 60, Special Aspects of Geriatric Pharmacology, Alzheimer disease
مرجع تعليمي، وليس استشارة طبية أو تشخيصاً أو علاجاً.